Even if clinical trials suggest tolerability, the real-world risk profile changes when: the source and purity of the peptide are uncertain, its used in different routes than studied, its used in stacked protocols with other drugs, its used in populations the trials didnt represent
Skovgrd K, Barrientos SA, Petersson P et al (2023) Distinctive effects of D1 and D2 receptor agonists on cortico-basal ganglia oscillations in a rodent model of L-DOPA-Induced dyskinesia
The high purity level, above 98% as determined by HPLC, meets the quality standards for scientific research
Biological age and telomere lengths were measured at baseline, 9 months, and 16 months using TruAge
Increased risk of cancer in infertile men: analysis of U.S
Regulatory compliance separates survivors from casualties